1-(4-(Trifluoromethoxy)phenyl)propan-1-amine hydrochloride, 98%, 250mg

tert-Butyl 4-(hydroxymethyl)-2-azabicyclo[2.1.1]hexane-2-carboxylate, 97%, 100mg

Hydroxyde de calcium, min 96%, pa, 1 kg, emballage plastique.

Ethyl 6-methoxypyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 50mg

(2R,6S)-2,6-dimethyl-4-(4-piperidinyl)morpholine dihydrochloride hydrate, 95.0%, 5g

3-Bromo-4-methylpyridine>98.0%(GC)(T)5g

(R)-methyl 2-((R)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoate, 95%, 250mg

(3aR,8aS)-2-(Quinolin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 250mg

Bis[2-(diisopropylphosphino)ethyl]amine (ca. 10% in Tetrahydrofuran)1g

2-Bromotetrafluoroethyl trifluorovinyl ether, 97.0%, 5g

delta-Valerolactam, 98.0%, 10g

2-Oxopiperidine-4-carboxylic acid, 95.0%, 10g

4-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE, 95.0%, 5g